Fingerprint
Dive into the research topics of 'Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically